Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway
Crossref DOI link: https://doi.org/10.1038/aps.2015.4
Published Online: 2015-04-13
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zheng, Yuan-ting
Yang, Hui-ying
Li, Tao
Zhao, Bei
Shao, Teng-fei
Xiang, Xiao-qiang
Cai, Wei-min
Text and Data Mining valid from 2015-04-13
Article History
Received: 28 September 2014
Accepted: 8 January 2015
First Online: 13 April 2015